share_log

Silver Bullet Mines Corp. Provides Update on The Buckeye Mine High Grade Gold, Platinum, and Palladium and Provides First Stage Check of Initial Assays Results

Silver Bullet Mines Corp. Provides Update on The Buckeye Mine High Grade Gold, Platinum, and Palladium and Provides First Stage Check of Initial Assays Results

銀彈礦業股份有限公司提供七葉樹礦高品位金、白金和鈀金的最新資訊,並提供初步檢測結果的第一階段檢查
newsfile ·  2023/03/03 04:11

Burlington, Ontario--(Newsfile Corp. - March 2, 2023) - Silver Bullet Mines Corp. (TSXV: SBMI) (OTCQB: SBMCF) ('SBMI' or 'the Company'). Based on a review of the Company's technical disclosure by staff of the Ontario Securities Commission the Company is issuing the following update.

安大略省伯靈頓-(Newsfile Corp.-2023年3月2日)-銀彈礦業公司(多倫多證券交易所股票代碼:SBMI)(場外交易市場代碼:SBMCF)(以下簡稱:SBMI或公司)。根據安大略省證券委員會工作人員對該公司技術披露的審查,該公司發佈以下更新。

On September 26, 2022 and October 18, 2022 the Company disclosed high-grade gold, platinum, palladium, rhodium, and osmium (the "Bonus Materials") results from the Buckeye Mine from the in initial lab.

2022年9月26日和2022年10月18日,該公司披露了七葉樹礦在初始實驗室中的高品位金、鉑、鈀、銠和Os(“紅利材料”)結果。

The Company has subsequently received results on or about January 17, 2023 from six referee/check samples submitted to another independent third-party lab (Activation Laboratories Inc. (Actlabs)) which puts these previously released assay results into question. These new results indicate an absence of gold, palladium, and platinum. Please see the table below.

該公司隨後在2023年1月17日左右收到了提交給另一家獨立第三方實驗室(Activation實驗室Inc.(Actlabs))的6份推薦人/檢查樣本的結果,這對之前公佈的這些測試結果提出了質疑。這些新的結果表明,金、鈀和鉑是不存在的。請見下表。

Assay Results
Actlabs Certificate No. Initial Lab (ppb) Actlabs (ppb)
Sample No. Initial Lab Actlabs Au Pd Pt Au Pd Pt
I342175 2210001-11 A22-18646 22900 10400 61 2 < 5 < 5
I342176 2210001-10 A22-18646 30600 13600 70 3 < 5 < 5
I342177 2210001-1 A22-18646 14600 18900 50 4 < 5 5
I342178 2210001-12 A22-18646 81700 15900 93 < 2 < 5 < 5
I342179 2210001-8 A22-18646 31800 16009 93 5 < 5 < 5
I342180 (Duplicate) 2210001-1 A22-18646 14600 18900 172 < 2 < 5 < 5
I342181 (Standard) A22-18646 88 683 581
I342182 (blank) A22-18646 < 2 < 5 < 5
化驗結果
Actlabs 證書編號 初始實驗(Ppb) Actlabs(Ppb)
樣本號 初始實驗 Actlabs Au 局部放電 PT Au 局部放電 PT
I342175 2210001-11 A22-18646 22900 10400 61 2
I342176 2210001-10 A22-18646 30600 13600 70 3
I342177 2210001-1 A22-18646 14600 18900 50 4 5
I342178 2210001-12 A22-18646 81700 15900 93
I342179 2210001-8 A22-18646 31800 16009 93 5
I342180(複製) 2210001-1 A22-18646 14600 18900 172
I342181(標準) A22-18646 88 683 581
I342182(空白) A22-18646

Notes:

備註:

1) Standard used for sample I342181 was CDN-PGMS-29 a certified reference material with expected values of Au (88 ppb), Pd (677 ppb), and Pt (550 ppb)
2) Blank used for sample I342182 was barren silica material.

1)樣品I342181使用的標準是CDN-PGMS-29,一種經過認證的標準物質,期望值為Au(88 Ppb)、Pd(677 Ppb)和鉑(550 Ppb)
2)樣品I342182所用空白為無硅材料。

Investors should not rely on the assay results previously reported by the Company on September 26, 2022 and October 18, 2022.

投資者不應依賴本公司此前於2022年9月26日和2022年10月18日報告的化驗結果。

In addition, the Company's November 3, 2022 news release indicated that assay results from samples of diabase at several locations near and in the Buckeye Silver Mine were received and were being considered and would be disclosed to the public as soon as possible. Based on six referee/check samples noted above, the Company does not intend to disclose these results as they are considered unreliable at this time.

此外,公司2022年11月3日的新聞稿顯示,已收到七葉樹銀礦附近和幾個地點輝綠巖樣本的化驗結果,並正在考慮中,並將儘快向公眾披露。基於上述六個推薦人/支票樣本,本公司不打算披露這些結果,因為它們目前被認為是不可靠的。

The Company has engaged and sent samples to another independent certified lab (Third Lab). The Third Lab is performing check assay results using the same analytical method as the initial lab. Such results will be disclosed immediately upon receipt.

該公司已聘請另一家獨立認證實驗室並將樣本送往(第三個實驗室)。第三個實驗室正在使用與最初實驗室相同的分析方法進行檢查化驗結果。這些結果將在收到後立即披露。

The QAQC set out below is important as Actlabs that completed the check assays followed an analytical process different from the initial lab that produced the data reported by the Company on September 26, 2022 and October 18, 2022.

下面列出的QAQC非常重要,因為完成檢查化驗的Actlabs遵循了與最初實驗室不同的分析程序,最初的實驗室產生了公司於2022年9月26日和2022年10月18日報告的數據。

QAQC

QAQC

The Company had retained representative material from which each of the initial lab samples were obtained. A total of 6 samples inclusive of one duplicate were selected by the Company's QP, Robert G. Komarechka P.Geo., from this material and secured in sealed and labeled sample bags and delivered to a local courier in Globe, Arizona who then forwarded the samples on to Actlabs in Thunder Bay. The shipment also included duplicates, standards and blanks. In addition, Actlabs also used its own standards, blanks and duplicates. Actlabs undertook assaying of these 6 samples using ICP (induced coupled plasma) followed by OES (optical emission spectroscopy) analysis. This is a different analytical analysis used by the initial lab which was by MS (mass spectroscopy). SBMI is investigating whether the difference in process could explain the discrepancy in results.

該公司保留了具有代表性的材料,每一份最初的實驗室樣本都是從這些材料中獲得的。該公司的QP Robert G.Komarechka P.Geo從該材料中挑選了6個樣品,其中包括一個副本,並將其固定在密封並貼上標籤的樣品袋中,然後交付給亞利桑那州Globe的一名當地快遞員,後者隨後將樣品轉發給桑德貝的Actlabs。這批貨物還包括複製品、標準和空白。此外,Actlabs還使用了自己的標準、空白和複製品。Actlabs對這6個樣品進行了ICP(誘導耦合等離子體)和OES(光學發射光譜分析)分析。這是最初實驗室使用的一種不同的分析方法,即MS(質譜學)。SBMI正在調查過程中的差異是否可以解釋結果的差異。

Mr. Robert G. Komarechka, P.Geo., an independent consultant, has reviewed and verified SBMI's work referred to herein, and is the Qualified Person for this release.

獨立顧問Robert G.Komarechka,P.Geo已經審查和驗證了本文提及的SBMI的工作,是本新聞稿的合格人選。

For further information, please contact:

如需更多信息,請聯繫:

John Carter
Silver Bullet Mines Corp., CEO
cartera@sympatico.ca
+1 (905) 302-3843

約翰·卡特
銀彈礦業公司,首席執行官
郵箱:cartera@sympatico.ca
+1 (905) 302-3843

Peter M. Clausi
Silver Bullet Mines Corp., VP Capital Markets
pclausi@brantcapital.ca
+1 (416) 890-1232

彼得·M·克勞西
資本市場副總裁Silver Bullet Mines Corp.
郵箱:pClausi@brantcapal.ca
+1 (416) 890-1232

Cautionary and Forward-Looking Statements

警告性和前瞻性陳述

This news release contains certain statements that constitute forward-looking statements as they relate to SBMI and its subsidiaries. Forward-looking statements are not historical facts but represent management's current expectation of future events, and can be identified by words such as "believe", "expects", "will", "intends", "plans", "projects", "anticipates", "estimates", "continues" and similar expressions. Although management believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that they will prove to be correct.

本新聞稿包含一些與SBMI及其子公司有關的前瞻性陳述。前瞻性陳述不是歷史事實,而是代表管理層目前對未來事件的預期,可以通過“相信”、“預期”、“將”、“打算”、“計劃”、“項目”、“預期”、“估計”、“繼續”等詞語來識別。儘管管理層認為這些前瞻性陳述中的預期是合理的,但不能保證它們將被證明是正確的。

By their nature, forward-looking statements include assumptions, and are subject to inherent risks and uncertainties that could cause actual future results, conditions, actions or events to differ materially from those in the forward-looking statements. If and when forward-looking statements are set out in this new release, SBMI will also set out the material risk factors or assumptions used to develop the forward-looking statements. Except as expressly required by applicable securities laws, SBMI assumes no obligation to update or revise any forward-looking statements. The future outcomes that relate to forward-looking statements may be influenced by many factors, including but not limited to: the impact of SARS CoV-2 or any other global virus; reliance on key personnel; the thoroughness of its QA/QA procedures; the continuity of the global supply chain for materials for SBMI to use in the production and processing of mineralized material; the presence of mineable economic mineralized material; shareholder and regulatory approvals; activities and attitudes of communities local to the location of the SBMI's properties; risks of future legal proceedings; income tax matters; fires, floods and other natural phenomena; the rate of inflation; availability and terms of financing; distribution of securities; commodities pricing; currency movements, especially as between the USD and CDN; effect of market interest rates on price of securities; and, potential dilution. SARS CoV-2 and other potential global pathogens create risks that at this time are immeasurable and impossible to define.

就其性質而言,前瞻性陳述包括假設,並受內在風險和不確定因素的影響,這些風險和不確定性可能導致未來的實際結果、條件、行動或事件與前瞻性陳述中的結果、條件、行動或事件大不相同。如果在這一新的新聞稿中陳述了前瞻性陳述,SBMI還將陳述用於制定前瞻性陳述的重大風險因素或假設。除非適用的證券法明確要求,否則SBMI不承擔更新或修改任何前瞻性陳述的義務。與前瞻性陳述有關的未來結果可能受到許多因素的影響,包括但不限於:SARS CoV-2或任何其他全球病毒的影響;對關鍵人員的依賴;其質量保證/質量保證程序的徹底性;供SBMI用於礦化材料生產和加工的材料的全球供應鏈的連續性;是否存在可開採的經濟礦化材料;股東和監管機構的批准;SBMI資產所在地社區的活動和態度;未來法律訴訟的風險;所得税問題;火災、洪水和其他自然現象;通貨膨脹率;可獲得性和融資條件;證券的分配;商品定價;貨幣變動,特別是美元和加拿大元之間的匯率變動;市場利率對證券價格的影響;以及潛在的攤薄。SARS CoV-2和其他潛在的全球病原體造成的風險目前是無法衡量和無法定義的。

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論